NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Indian IT Services Industry Remains Resilient Amid GenAI Fears

Nuvama Institutional Equities, a leading brokerage firm, has released a report stating that the adoption of Generative AI (GenAI) does not pose an existential threat to the Indian IT services industry. Despite the recent correction in IT stocks, the firm remains positive on the sector from a medium to long-term perspective.

The Nifty IT index has plunged 21% since the beginning of the year, with large-cap IT stocks falling 20% and midcaps IT stocks correcting 25% over the same period. However, this correction has occurred despite a reasonable performance in Q3FY26 and an improving outlook, as demonstrated by strong deal-wins.

The sharp correction has made valuations highly attractive, said Nuvama, which now has a 'Buy' call on all the top-ten IT stocks. The firm upgraded its rating on HCL Technologies, Wipro, Tech Mahindra, and Hexaware Technologies to 'Buy'. It prefers Coforge, LTIMindtree, Persistent Systems, Mphasis, Infosys, and Tata Consultancy Services (TCS).

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Key Rating Changes:

  • HCL Technologies: Upgraded to 'Buy' from 'Hold' with a target price of ₹1,550
  • Wipro: Upgraded to 'Buy' from 'Hold' with a target price of ₹240
  • Hexaware Technologies: Upgraded to 'Buy' with a reduced target price of ₹550
  • TCS: Target price reduced to ₹3,300 from ₹3,750
  • Infosys: Target price reduced to ₹1,650 from ₹1,900
  • LTIMindtree: Target price reduced to ₹6,100 from ₹7,750
  • Coforge: Target price reduced to ₹2,100 from ₹2,500
  • Persistent Systems: Target price reduced to ₹6,000 from ₹7,700
  • Mphasis: Target price reduced to ₹3,100 from ₹3,400

Investor Takeaway

Investors may find IT stocks appealing due to highly appealing valuations.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.